Chronic mucocutaneous candidiasis. II. Class and subclass of specific antibody responses in vivo and in vitro

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 213-219

  Lilic, D ^a,c   Calvert, J E ^a   Cant, A J ^b   Abinun, M ^b   Spickett, G P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antibody class and subclass; Candida pneumococcal polysaccharide tetanus antigens; Chronic mucocutaneous candidiasis; Specific antibody responses

Indexed keywords

ALPHA INTERFERON; CANDIDA ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; PNEUMOCOCCUS POLYSACCHARIDE; TETANUS TOXOID;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MUCOCUTANEOUS CANDIDIASIS; PRIORITY JOURNAL;

EID: 0030017678     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-765.x     Document Type: Article

References (20)

1. Kirkpatrick CH. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis 1989; 8:448-56.
2. Bodey GP. Candidiasis: pathogenesis, diagnosis and treatment, 2nd edn. New York: Raven Press, 1993.
3. Edwards JE, moderator UCLA conference. Severe candidal infections. Clinical perspective, immune defense mechanisms and current concepts of therapy. Ann Int Med 1978; 89:91-106.
4. Valdimarsson H, Higgs JM, Wells M Y et al. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol 1973; 6:348-61.
5. Herrod HG. Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: report of the pediatric immunodeficiency collaborative study group. J Pediatrics 1990; 116:377-82.
6. Bentur L, Nisbet-Brown E, Levison H et al. Lung disease associated with IgG subclass deficiency in chronic mucocutaneous candidiasis. J Pediatrics 1991; 118:82-86.
7. Romani L, Mocci S, Bietta C. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 1992; 59:4647-54.
8. Finkelman FD, Scetic A, Gresser I et al. Regulation by IFNα of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 1991; 174:1179-88.
9. Peeters CCA, Tenbergen-Meekes AM, Heijnen CJ et al. IFNγ and IL-6 augment the human in vitro antibody response to the HIB polysaccharide. J Infect Dis 1992; 163 (Suppl. 1): s160 s162.
10. Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP. Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-γ) production. Clin Exp Immunol 1996; 105:205-12.
11. Falconer AE, Carson R, Johnstone R. Distinct IgG1 and IgG3 subclass responses to two streptococcal protein antigens in man: analysis of antibodies to streptolysin O and M protein using standardised subclass-specific ELISA. Immunology 1993;79:89-94.
12. Hernando FL, Cailliez JC, Trinel PA et al. Qualitative and quantitative differences in recognition patterns of Candida albicans protein and polysaccharide antigens by human sera. J Med Vet Mycology 1993;31:219-26.
13. Matthews RC, Burnie JP, Tabaqchali S. Isolation of immuno-dominant antigens from sera of patients with systemic candidiasis and characterisation of serological response to Candida albicans. J Clin Microbiol 1987; 25:230-7.
14. van Vlasselaer P, Punnonnen J, de Vries JE. TGFβ directs IgA switching in human B cells. J Immunol 1992; 148:2062-7.
15. Shackelford PG, Granoff DM, Madassery JV. Clinical and immunological characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res 1990; 27:16-22.
16. Frame JD, Everitt AS, Gordon PW, Hackett ME. IgG subclass response to gamma globulin administration in burned children. Burns 1990; 16:437-40.
17. Bannister KM, Howarth GS, Clarkson AR et al. Glomerular IgG subclass distribution in glomerulonephritis. Clin Nephrol 1983; 19:161-5.
18. Todd A, Coan R, Alien A. Pigeon breeders' lung; IgG subclasses to pigeon intestinal mucin and IgA antigens. Clin Exp Immunol 1993; 92:494-9.
19. Durandy A, Fisher A, Le Deist F, Drouhet E, Griscelli C. Mannan-speciflc and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol 1987; 7:400-9.
20. Calandra T, Bernhagen J, Metz CN et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377:68-71.